EUVIMEDEUVIMED entdecken
Open Access

HIV Prevalence and Characteristics Among Patients With AIDS-Defining and Non–AIDS-Defining Cancers in a Tertiary Hospital in Kenya

Diana Muturi iD, Sitna N Mwanzi iD, Felix M Riunga iD, Jasmit Shah iD, Reena Shah iD

JCO Global Oncology · 2023

DOI: 10.1200/go.22.00360 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Global Oncology, 2023. Verfasst von Diana Muturi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Aga Khan University, Nairobi, Kenya. Hauptthemen laut MEDLINE: HIV Infections, Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Antiretroviral therapy (ART) has resulted in a higher life expectancy of persons living with HIV. This has led to an aging population at risk for both non–AIDS-defining cancers (NADCs) and AIDS-defining cancers (ADCs). HIV testing among patients with cancer in Kenya is not routinely performed, making its prevalence undefined. The aim of our study was to determine the prevalence of HIV and the spectrum of malignancies among HIV-positive and HIV-negative patients with cancer attending a tertiary hospital in Nairobi, Kenya. MATERIALS AND METHODS We conducted a cross-sectional study between February 2021 and September 2021. Patients with a histologic cancer diagnosis were enrolled. Demographic data and HIV- and cancer-related clinical variables were obtained. HIV pretest counseling and consent were done, and testing was performed using a fourth-generation assay. Positive results were confirmed using a third-generation assay. RESULTS We enrolled 301 patients with cancer; 67.8% (204 of 301) were female; the mean age was 50.7 ± 12.5 years. From our cohort, 10.6% (95% CI, 7.4 to 14.7, n = 32 of 301) of patients were HIV-positive with the prevalence of a new HIV diagnosis of 0.7% (n = 2 of 301). Of the HIV-positive patients, 59.4% (19 of 32) had a NADC. The commonest NADC was breast cancer (18.8%; 6 of 32), whereas non-Hodgkin lymphoma (18.8%; 6 of 32) and cervical cancer (18.8%; 6 of 32) were the most prevalent ADCs among HIV-positive patients. CONCLUSION The prevalence of HIV infection among patients with cancer was twice the Kenya national HIV prevalence. NADCs comprised a larger percentage of the cancer burden. Universal opt-out HIV testing of patients attending for cancer care regardless of cancer type may facilitate early recognition of HIV-infected patients and aid in appropriate selection of ART and cancer therapies and preventive strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAcquired Immunodeficiency SyndromeUterine Cervical NeoplasmsHumansFemaleAgedAdultMiddle AgedMaleTertiary Care CentersPrevalenceCross-Sectional StudiesKenya

Autor:innen und Institutionen

  • Department of Internal Medicine, Aga Khan University, Nairobi, Kenya.
  • Department of Haemato-Oncology, Aga Khan University, Nairobi, Kenya.

ORCID-Profile: Diana Muturi, Sitna N Mwanzi, Felix M Riunga, Jasmit Shah, Reena Shah

Zitieren

APA

Muturi, D., Mwanzi, S. N., Riunga, F. M., Shah, J., & Shah, R. (2023). HIV Prevalence and Characteristics Among Patients With AIDS-Defining and Non–AIDS-Defining Cancers in a Tertiary Hospital in Kenya. JCO Global Oncology. https://doi.org/10.1200/go.22.00360

Vancouver

Muturi D, Mwanzi SN, Riunga FM, Shah J, Shah R. HIV Prevalence and Characteristics Among Patients With AIDS-Defining and Non–AIDS-Defining Cancers in a Tertiary Hospital in Kenya. JCO Global Oncology. 2023. doi:10.1200/go.22.00360

BibTeX
@article{Muturi2023,
  author = {Muturi, Diana and Mwanzi, Sitna N and Riunga, Felix M and Shah, Jasmit and Shah, Reena},
  title = {HIV Prevalence and Characteristics Among Patients With AIDS-Defining and Non–AIDS-Defining Cancers in a Tertiary Hospital in Kenya},
  journal = {JCO Global Oncology},
  year = {2023},
  doi = {10.1200/go.22.00360}
}
Kostenlos starten →